Drugs and other treatments can be life-saving, but sometimes those life-saving abilities can also have harmful side effects. Researchers at the University of Washington were looking for a way to… Read More
Impel NeuroPharma, a Seattle-based biotechnology and pharmaceutical company, announced a $36 million Series C round to develop neurological drugs and an accompanying delivery device that bypasses the blood-brain barrier. The… Read More